A recent report published by Infinium Global Research on migraine
drugs market provides in-depth analysis of segments and sub-segments in global
as well as regional migraine drugs market. The study also highlights the impact
of drivers, restraints and macro indicators on the global and regional migraine
drugs market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of the global
migraine drugs market. According to the report the global migraine drugs market is
projected to grow at a CAGR of 5.5% over the forecast period of 2018-2024.
The report on global migraine drugs market covers segments such
as therapeutic class and treatment type. On the basis of therapeutic class the
global migraine drugs market is categorized into ergots, triptans, and others.
On the basis of treatment type, the global migraine drugs market is categorized
into abortive and preventive.
The report provides regional analysis covering geographies such as
North America, Europe, Asia-Pacific, and Rest of the World. In this section, the
key trends and market size for each geography are provided over the period of 2016-2024.
The countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia,
and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe
are included in the European region. The U.S. drives the growth in the North
America region as it is the largest market in the region. The Asia-pacific the region offers a substantial potential for the market growth owing to rapid
growth in markets such as India and China.
The APAC region is projected to experience a growth at a CAGR of x.x%
over the period of 2018-2024.
The report provides profiles of the companies in the global
migraine drugs market such as Winston Pharmaceuticals, Luitpold
Pharmaceuticals, GlaxoSmithKline, Eli Lilly, Allergan, Impax Laboratories,
Alder Biopharmaceuticals, Pfizer, TG Therapeutics, Aegis Therapeutics and
Johnson & Johnson.
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides
insights into the factors that are driving and restraining the global migraine
drugs market. Moreover, IGR-Growth Matrix analysis given in the report brings
an insight into the investment areas that existing or new market players can
consider. The report provides insights into the market using analytical tools
such as Porter's five forces analysis and DRO analysis of migraine drugs
market. Moreover, the study highlights current market trends and provides
forecast from 2018-2024. We also have highlighted future trends in the migraine
drugs market that will impact the demand during the forecast period. Moreover,
the competitive analysis given in each regional market brings an insight into the
market share of the leading players. This report will help manufacturers,
suppliers, and distributors of the migraine drugs market to understand the
present and future trends in this market and formulate their strategies